Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 12, 2007, Pages 4236-4242

  Saitoh, Akihiko ^a   Fenton, Terence ^c   Alvero, Carmelita ^c   Fletcher, Courtney V ^d   Spector, Stephen A ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; MITOCHONDRIAL DNA; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CELL CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MITOCHONDRION; MULTIVARIATE ANALYSIS; PEDIATRICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS DETECTION;

ADOLESCENT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BENZOXAZINES; BODY MASS INDEX; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DNA, MITOCHONDRIAL; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPIDS; LONGITUDINAL STUDIES; MITOCHONDRIA; NELFINAVIR; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL;

EID: 36749058372     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00893-07     Document Type: Article

References (52)

1. Aldrovandi, G., J. Moye, C. Chu, W. Meyer, B. Ha, E. Handelsman, W. Shearer, M. Foca, K. Rich, K. McIntosh, and the Women and Infants Transmission Study Group. 2006. Mitochondrial DNA content of peripheral blood mononuclear cells in uninfected infants born to HIV-infected women with or without ART exposure in the Women and Infants Transmission Study, abstr. 695. Abstr. 13th Conf. Retrovir. Opportun. Inf.
2. Birkus, G., M. J. Hitchcock, and T. Cihlar. 2002. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob. Agents Chemother. 46:716-723.
3. Brinkman, K. 2005. Lipoatrophy and mitochondrial DNA assays: see all, know all? AIDS 19:91-92.
4. Caron, M., M. Auclair, C. Lagathu, A. Lombes, U. A. Walker, M. Kornprobst, and J. Capeau. 2004. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. AIDS 18:2127-2136.
5. Carr, A. 2003. Toxicity of antiretroviral therapy and implications for drug development. Nat. Rev. Drug Discov. 2:624-634.
6. Casula, M., I. Bosboom-Dobbelaer, K. Smolders, S. Otto, M. Bakker, M. P. de Baar, P. Reiss, and A. de Ronde. 2005. Infection with HIV-1 induces a decrease in mtDNA. J. Infect. Dis. 191:1468-1471.
7. Casula, M., N. Vrisekoop, F. W. Wit, M. P. Baar, A. Ronde, F. Miedema, and P. Reiss. 2007. Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation. J. Infect. Dis. 196:371-376.
8. Casula, M., G. J. Weverling, F. W. Wit, E. C. Timmermans, M. Stek, Jr., J. M. Lange, and P. Reiss. 2005. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. J. Infect. Dis. 192:1794-1800.
9. Cherry, C. L., M. E. Gahan, J. C. McArthur, S. R. Lewin, J. F. Hoy, and S. L. Wesselingh. 2002. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J. Acquir. Immune Defic. Syndr. 30:271-277.
10. Cherry, C. L., D. Nolan, I. R. James, E. J. McKinnon, S. A. Mallal, M. E. Gahan, L. Lal, J. C. McArthur, and S. L. Wesselingh. 2006. Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 42:435-440.
11. Chiappini, F., E. Teicher, R. Saffroy, P. Pham, B. Falissard, A. Barrier, S. Chevalier, B. Debuire, D. Vittecoq, and A. Lemoine. 2004. Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients. Lab. Investig. 84:908-914.
12. Christopherson, C., Y. Kidane, B. Conway, J. Krowka, H. Sheppard, and S. Kwok. 2000. PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J. Clin. Microbiol. 38:630-634.
13. Cossarizza, A. 2003. Tests for mitochondrial function and DNA: potentials and pitfalls. Curr. Opin. Infect. Dis. 16:5-10.
14. Cossarizza, A., M. Pinti, L. Moretti, D. Bricalli, R. Bianchi, L. Troiano, M. G. Fernandez, F. Balli, P. Brambilla, C. Mussini, and A. Vigano. 2002. Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy. J. Infect. Dis. 185: 299-305.
15. Cossarizza, A., A. Riva, M. Pinti, S. Ammannato, P. Fedeli, C. Mussini, R. Esposito, and M. Galli. 2003. Increased mitochondrial DNA content in peripheral blood lymphocytes from HIV-infected patients with lipodystrophy. Antivir. Ther. 8:315-321.
16. Cote, H., J. Forbes, A. Bitnun, J. Raboud, D. Money, E. Maan, C. Diong, R. Harrigan, A. Alimenti, and S. Reed. 2007. Mitochondrial DNA and mtRNA levels during perinatal ART exposure in HIV-uninfected infants born to HIV-infected mothers, abstr. 714. Abstr. 14th Conf. Retrovir. Opportunistic Infect.
17. Cote, H. C., Z. L. Brumme, K. J. Craib, C. S. Alexander, B. Wynhoven, L. Ting, H. Wong, M. Harris, P. R. Harrigan, M. V. O'Shaughnessy, and J. S. Montaner. 2002. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N. Engl. J. Med. 346:811-820.
18. Cote, H. C., B. Yip, J. J. Asselin, J. W. Chan, R. S. Hogg, P. R. Harrigan, M. V. O'Shaughnessy, and J. S. Montaner. 2003. Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens. J. Infect. Dis. 187:1972-1976.
19. Cui, L., L. Locatelli, M. Y. Xie, and J. P. Sommadossi. 1997. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. J. Pharmacol. Exp. Ther. 280:1228-1234.
20. de Baar, M. P., E. R. de Rooij, K. G. Smolders, H. B. van Schijndel, E. C. Timmermans, and R. Bethell. 2007. Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells. Antivir. Res. 76:68-74.
21. Gerschenson, M., and K. Brinkman. 2004. Mitochondrial dysfunction in AIDS and its treatment. Mitochondrion 4:763-777.
22. Gortmaker, S. L., M. Hughes, J. Cervia, M. Brady, G. M. Johnson, G. R. Seage III, L. Y. Song, W. M. Dankner, and J. M. Oleske. 2001. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N. Engl. J. Med. 345:1522-1528.
23. Hoschele, D. 2006. Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity. Toxicol. In Vitro 20:535-546.
24. Hoy, J. F., M. E. Gahan, A. Carr, D. Smith, S. R. Lewin, S. Wesselingh, and D. A. Cooper. 2004. Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir. J. Infect. Dis. 190:688-692.
25. Johnson, A. A., A. S. Ray, J. Hanes, Z. Suo, J. M. Colacino, K. S. Anderson, and K. A. Johnson. 2001. Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase. J. Biol. Chem. 276:40847- 40857.
26. Komarov, A. M., J. M. Hall, and W. B. Weglicki. 2004. Azidothymidine promotes free radical generation by activated macrophages and hydrogen peroxide-iron-mediated oxidation in a cell-free system. Biochim. Biophys. Acta 1688:257-264.
27. Lee, H. C., P. H. Yin, C. Y. Lu, C. W. Chi, and Y. H. Wei. 2000. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 348(Pt. 2):425-432.
28. Lim, S. E., and W. C. Copeland. 2001. Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J. Biol. Chem. 276:23616-23623.
29. Lund, K. C., L. L. Peterson, and K. B. Wallace. 2007. Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs. Antimicrob. Agents Chemother. 51:2531-2539.
30. Martin, J. L., C. E. Brown, N. Matthews-Davis, and J. E. Reardon. 1994. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob. Agents Chemother. 38:2743-2749.
31. McComsey, G., R. K. Bai, J. F. Maa, D. Seekins, and L. J. Wong. 2005. Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion. J. Acquir. Immune Defic. Syndr. 39:181-188.
32. McComsey, G., D. J. Tan, M. Lederman, E. Wilson, and L. J. Wong. 2002. Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy. AIDS 16:513-518.
33. McComsey, G. A., and E. Leonard. 2004. Metabolic complications of HIV therapy in children. AIDS 18:1753-1768.
34. McComsey, G. A., D. M. Paulsen, J. T. Lonergan, S. M. Hessenthaler, C. L. Hoppel, V. C. Williams, R. L. Fisher, C. L. Cherry, C. White-Owen, K. A. Thompson, S. T. Ross, J. E. Hernandez, and L. L. Ross. 2005. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS 19:15-23.
35. Miller, T. L., B. E. Mawn, E. J. Orav, D. Wilk, G. A. Weinberg, J. Nicchitta, L. Furuta, R. Cutroni, K. McIntosh, S. K. Burchett, and S. L. Gorbach. 2001. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics 107:E77.
36. Miro, O., S. Lopez, E. Martinez, E. Pedrol, A. Milinkovic, E. Deig, G. Garrabou, J. Casademont, J. M. Gatell, and F. Cardellach. 2004. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin. Infect. Dis. 39:710-716.
37. Pan-Zhou, X. R., L. Cui, X. J. Zhou, J. P. Sommadossi, and V. M. Darley-Usmar. 2000. Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrob. Agents Chemother. 44:496-503.
38. Petit, C., D. Mathez, C. Barthelemy, T. Leste-Lasserre, R. K. Naviaux, P. Sonigo, and J. Leibowitch. 2003. Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion. J. Acquir. Immune Defic. Syndr. 33:461-469.
39. Phanuphak, P. 2004. Antiretroviral treatment in resource-poor settings: what can we learn from the existing programmes in Thailand? AIDS 18(Suppl. 3):S33-S38.
40. Ray, A. S., Z. Yang, C. K. Chu, and K. S. Anderson. 2002. Novel use of a guanosine prodrug approach to convert 2′,3′-didehydro- 2′,3′-dideoxyguanosine into a viable antiviral agent. Antimicrob. Agents Chemother. 46:887-891.
41. Reiss, P., M. Casula, A. de Ronde, G. J. Weverling, J. Goudsmit, and J. M. Lange. 2004. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine + didanosine or zidovudine + zalcitabine) single (zidovudine) nucleoside reverse transcriptase inhibitors. HIV Med. 5:11-14.
42. Roat, E., N. Prada, R. Ferraresi, C. Giovenzana, M. Nasi, L. Troiano, M. Pinti, E. Nemes, E. Lugli, O. Biagioni, M. Mariotti, L. Ciacci, U. Consolo, F. Balli, and A. Cossarizza. 2007. Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett. 581:521-525.
43. Saitoh, A., N. Salva, J. K. Wong, and S. A. Spector. 2006. Impact of didanosine on mitochondrial DNA and RNA in human skeletal muscle myoblasts, abstr. H-1905. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
44. Saitoh, A., K. Hsia, T. Fenton, C. A. Powell, C. Christopherson, C. V. Fletcher, S. E. Starr, and S. A. Spector. 2002. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children. J. Infect. Dis. 185:1409-1416.
45. Setzer, B., M. Schlesier, and U. A. Walker. 2005. Effects of didanosine-related depletion of mtDNA in human T lymphocytes. J. Infect. Dis. 191: 848-855.
46. Spector, S. A., F. H. Yong, S. Cabral, T. Fenton, C. V. Fletcher, J. McNamara, L. M. Mofenson, and S. E. Starr. 2000. Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral tlTerapy in infected children. J. Infect. Dis. 182:1769-1773.
47. Starr, S. E., C. V. Fletcher, S. A. Spector, F. H. Yong, T. Fenton, R. C. Brundage, D. Manion, N. Ruiz, M. Gersten, M. Becker, J. McNamara, L. M. Mofenson, L. Purdue, S. Siminski, B. Graham, D. M. Kornhauser, W. Fiske, C. Vincent, H. W. Lischner, W. M. Dankner, P. M. Flynn, et al. 1999. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. N. Engl. J. Med. 341:1874-1881.
48. van der Valk, M., M. Casula, G. J. Weverlingz, K. van Kuijk, B. van Eck-Smit, H. J. Hulsebosch, P. Nieuwkerk, A. van Eeden, K. Brinkman, J. Lange, A. de Ronde, and P. Reiss. 2004. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. Antivir. Ther. 9:385-393.
49. Verweel, G., A. M. van Rossum, N. G. Hartwig, T. F. Wolfs, H. J. Scherpbier, and R. de Groot. 2002. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 109:E25.
50. Walker, U. A., B. Setzer, and N. Venhoff. 2002. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS 16:2165-2173.
51. Wei, Y. H., C. F. Lee, H. C. Lee, Y. S. Ma, C. W. Wang, C. Y. Lu, and C. Y. Pang. 2001. Increases of mitochondrial mass and mitochondrial genome in association with enhanced oxidative stress in human cells harboring 4,977 BP-deleted mitochondrial DNA. Ann. N. Y. Acad. Sci. 928:97-112.
52. World Health Organization. 2006. Antiretroviral treatment of HIV infection in infants and children in resource-limited settings, towards universal access. Recommendations for a public health approach. http://www.who.int/hiv/pub /guidelines/en/. World Health Organization, Geneva, Switzerland.